← Evidence map

TrialClinical drug investigation2012

Safety and tolerability of an SQ-standardized GRAss ALlergy immunotherapy tablet (GRAZAX®) in a real-life setting for three consecutive seasons - the GRAAL trial.

François Wessel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 22594491